eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | thrombocytopenia |
| Comorbidity | C0272286|immune thrombocytopenia |
| Sentences | 5 |
| PubMedID- 23292974 | Romiplostim, a thrombopoietin mimetic, is fda approved for the treatment of thrombocytopenia in patients with refractory immune thrombocytopenia. |
| PubMedID- 24623263 | To determine predictive factors for neonatal thrombocytopenia in deliveries with immune thrombocytopenia (itp), we conducted a retrospective study at a tertiary hospital between 1997 and 2013. |
| PubMedID- 22687850 | Highly fluctuating thrombocytopenia developing in a patient with immune thrombocytopenia (itp) while administering romiplostim. |
| PubMedID- 23008717 | Consistent with these observations, recent studies demonstrated that thrombocytopenia in patients with primary chronic autoimmune thrombocytopenia is associated with a significantly higher long-term risk of infection [73]. |
| PubMedID- 25170628 | Background/aim: thrombopoietin receptor agonists (romiplostim and eltrombopag) have recently been licensed for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia (itp) with an insufficient response to corticosteroids, immunoglobulins or splenectomy. |
Page: 1